Improving survival in pancreatic cancer with platinum-based chemotherapy

A small study of adults with the most common form of pancreatic cancer adds to evidence that patients with BRCA1 or BRCA2 gene mutations long linked to a high risk of breast cancer have poorer overall survival rates than those without the mutations.

Go to Source

(Visited 13 times, 1 visits today)

Site Footer

Sliding Sidebar